At a glance
Key figures
Illustrative figures shown for the purposes of this corporate website.
Share price (KRX)
₩48,250
▲ 1.8% today
Market capitalisation
₩2.1T
As of 2026
FY revenue
₩1.42T
▲ 11.4% YoY
Operating margin
18.6%
▲ 1.2pp YoY
R&D investment
13.0%
of revenue
Dividend per share
₩900
▲ 6% YoY
Resources
For shareholders
Financial reports
Quarterly and annual results, with consolidated financial statements.
Disclosures & filings
Regulatory filings and material disclosures to the exchange.
IR calendar
Earnings dates, the annual general meeting and investor events.
Recent disclosures
Latest investor news
18 Jun 2026
Corporate
Sungmoo opens a new medical-device production line at the Hwaseong plant
02 Jun 2026
R&D
Next-generation SGM Vesta patient monitor receives CE marking
21 May 2026
Sustainability
2025 ESG Report published: Scope 1 & 2 emissions down 22% year-on-year
09 May 2026
Partnership
Distribution agreement brings Sungmoo imaging systems to three new EU markets
Sungmoo Pharmaceutical
Investor enquiries
For questions from analysts, institutional and individual investors, our IR team is here to help.